# LLM Judge Evaluation: tier3_001

## Overall: FAIL

### Scores:
- **Completion**: 1/2
- **Correctness**: 1/2
- **Tool Use**: 1/2
- **Total**: 3/6

### Reasoning:
Completion:
- Multiple workflows were submitted (tautomers, micro/macro pKa, descriptors), but none reached a finished/successful state in the trace; several remained RUNNING/QUEUED and no retrieval step occurred. Despite this, the agent marked the run as “Completed.” Therefore, workflows were initiated but not completed, and no computed numerical outputs were reported from the tools.

Correctness:
- pKa: The agent’s interim pKa (≈4.9) is consistent with reputable literature values around 4.9–5.0, so this part is accurate.
- Tautomers: The agent reduced warfarin’s tautomerism to “4‑hydroxy vs 4‑keto.” High‑quality literature shows warfarin has extensive tautomerism, with cyclic hemiketal 4‑hydroxycoumarin tautomers predominating in aqueous solution; the agent’s description misses the known hemiketal dominance.
- Dominant microstate at pH 7.4: Given pKa ≈5, the anion is indeed dominant at pH 7.4; this is correct.
- Protein binding affinity: The agent predicted very tight HSA binding (10–50 nM), but published equilibrium measurements at pH ~7–7.4 indicate Ka ≈(3–10)×10^5 M^-1 (Kd ≈1–3 μM), i.e., roughly two orders of magnitude weaker than the agent’s nanomolar claim.

Tool use:
- Tools were appropriate for the task (structure lookup → tautomer search → pKa workflows → descriptors), but execution did not complete, there were repeated status polls without a retrieval step, and one pKa proxy submission errored. Thus, reasonable choice but with incomplete execution and some inefficiency/errors.

### Feedback:
- Do not mark runs “Completed” until workflows finish and you’ve retrieved outputs; include a retrieve step and report the actual computed numbers.
- Incorporate authoritative tautomer literature: warfarin’s dominant aqueous forms are cyclic hemiketal 4‑hydroxycoumarin tautomers, not just a simple hydroxy/keto pair.
- Your pKa estimate was good; once your pKa workflows finish, replace the estimate with the computed microscopic/macro pKa and show speciation at pH 7.4 numerically.
- Revisit the protein binding prediction: literature Kd for warfarin–HSA is ~1–3 μM at neutral pH, not nanomolar. If you perform docking, calibrate scoring to experimental Kd and avoid reporting implausibly tight affinities.
- Reduce redundant polling and handle tool errors (e.g., proxy pKa job failures) with retries or alternative validated inputs.
- Literature validation: - Property: pKa (acidic phenolic site of warfarin)
  1) Agent’s computed value: 4.9 (±0.3)
  2) Literature value and source: 5.0 (DrugBank experimental properties, citing Ufer 2005); 4.94 reported in BCRP transport study. ([go.drugbank.com](https://go.drugbank.com/drugs/DB00682?utm_source=openai))
  3) Absolute error (vs 5.0): |4.9 − 5.0| = 0.1 pKa units
  4) Percent error: 0.1/5.0 × 100% = 2%
  5) Score justification: Within ±0.5 pKa units; accurate.

- Property: Dominant microstate at pH 7.4
  1) Agent’s conclusion: Anionic phenoxide dominates at pH 7.4.
  2) Literature support: With pKa ≈ 4.94–5.0, Henderson–Hasselbalch predicts >99% deprotonation at pH 7.4; consistent with the statement that warfarin is mainly an anion at physiological pH. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/28093289/?utm_source=openai))

- Property: Major tautomers in aqueous solution
  1) Agent’s claim: 4‑hydroxy tautomer (major) vs 4‑keto (minor, +3–5 kcal/mol).
  2) Literature finding: Warfarin exhibits extensive tautomerism; aqueous solution favored forms are 4‑hydroxycoumarin cyclic hemiketal diastereomers, with an open‑chain 4‑hydroxy tautomer as a minor component (DFT + NMR). ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7724503/?utm_source=openai))
  3) Assessment: Agent omitted the experimentally supported cyclic hemiketal dominance.

- Property: Protein binding affinity to HSA (Sudlow site I)
  1) Agent’s predicted Kd: ~10–50 nM (central ~20 nM).
  2) Literature values: Equilibrium constants Ka ≈ (3.5–4.2)×10^5 M^-1 (8–37 °C), and ~5.8×10^5 M^-1 (pH ~7.1, I=0.1), corresponding to Kd ≈ 2–3 μM and 1.7 μM, respectively; single high‑affinity site in the 6–9 pH range. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai))
  3) Absolute error (vs 2.0 μM): |20 nM − 2.0 μM| = 1.98 μM
  4) Percent error: 1.98 μM / 2.0 μM × 100% ≈ 99% (≈100× too tight)
  5) Score justification: Off by orders of magnitude; not consistent with established experimental binding data.

### Web Search Citations:
1. [Warfarin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB00682?utm_source=openai)
2. [R- and S-Warfarin Were Transported by Breast Cancer Resistance Protein: From In Vitro to Pharmacokinetic-Pharmacodynamic Studies - PubMed](https://pubmed.ncbi.nlm.nih.gov/28093289/?utm_source=openai)
3. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC7724503/?utm_source=openai)
4. [Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study - PubMed](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai)

### Execution:
- **Tools**: submit_macropka_workflow, workflow_get_status, molecule_lookup, submit_tautomer_search_workflow, submit_descriptors_workflow, submit_pka_workflow
- **Time**: 12.6 min

---
*Evaluated with openai/gpt-5*
